Inactive Instrument

Viela Bio, Inc.

VIE

US9266131005

Biotechnology & Medical Research

Viela Bio, Inc.(NasdaqGS:VIE) dropped from S&P Global BMI Index

March 15, 2021 at 12:00 am EDT

Latest news about Viela Bio, Inc.

AstraZeneca : Closes $775 Million Sale of Stake in US-Based Viela Bio	21-03-16	MT
Horizon Therapeutics Public : Completes Viela Bio Acquisition	21-03-15	MT
Viela Bio, Inc. Announces Board Changes	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from S&P TMI Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from S&P Biotechnology Select Industry Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from S&P Global BMI Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2000 Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 3000 Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2500 Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2000 Growth Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell Small Cap Completeness Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell Small Cap Comp Growth Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 3000 Growth Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2500 Growth Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 3000E Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 3000E Growth Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2000 Dynamic Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2500 Dynamic Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2000 Growth-Dynamic Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from Russell 2500 Growth-Dynamic Index	21-03-15	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from NASDAQ Composite Index	21-03-15	CI
Horizon Therapeutics USA, Inc. completed the acquisition of Viela Bio, Inc. from AstraZeneca UK Limited and others.	21-03-14	CI
Viela Bio, Inc.(NasdaqGS:VIE) dropped from NASDAQ Biotechnology Index	21-03-12	CI
Correction: -- Earnings Flash (VIE) VIELA BIO Posts Q4 Revenue $9.4M, vs. Street Est of $5.55M	21-03-01	MT
Viela Bio : Q4 Loss Widens; Revenue Tops Consensus	21-03-01	MT

Viela Bio Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for severe inflammation and autoimmune diseases. Its product pipeline includes Inebilizumab, VIB4920 and VIB7734. Inebilizumab is a humanized mAb that binds to and depletes CD19+ B cells including plasmablasts and plasma cells. VIB4920 is a fusion protein designed to bind to CD40 ligand (CD40L) on activated T cells, blocking the interaction with CD40 expressed on B cells and preventing them from differentiating into plasma cells and memory B cells. VIB7734 is a treatment for autoimmune and related inflammatory diseases.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2.02%	102B
REGENERON PHARMACEUTICALS, INC.	+2.33%	96.09B
ARGENX SE	+2.13%	22.28B
BIONTECH SE	-16.80%	21.4B
GENMAB A/S	-8.79%	18.14B
WUXI APPTEC CO., LTD.	-39.98%	17.02B
BEIGENE, LTD.	-14.17%	16.09B
NEUROCRINE BIOSCIENCES, INC.	+5.20%	13.83B
SAREPTA THERAPEUTICS, INC.	+33.14%	11.97B

Bio Therapeutic Drugs

Viela Bio, Inc.

Equities

VIE

US9266131005

Biotechnology & Medical Research

Viela Bio, Inc.(NasdaqGS:VIE) dropped from S&P Global BMI Index

Latest news about Viela Bio, Inc.

Chart Viela Bio, Inc.

Company Profile

Sector Bio Therapeutic Drugs